학술논문

Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
Document Type
Journal Article
Source
British Journal of Cancer. Apr2021, Vol. 124 Issue 9, p1543-1551. 9p.
Subject
*SALIVA microbiology
*PAPILLOMAVIRUSES
*RESEARCH
*SALIVA
*RESEARCH methodology
*OROPHARYNGEAL cancer
*PROGNOSIS
*MEDICAL cooperation
*EVALUATION research
*COMPARATIVE studies
*PAPILLOMAVIRUS diseases
*ORAL mucosa
*LONGITUDINAL method
*SQUAMOUS cell carcinoma
*DISEASE complications
Language
ISSN
0007-0920
Abstract
Background: Oral and gut microbiomes have emerged as potential biomarkers in cancer. We characterised the oral and gut microbiomes in a prospective observational cohort of HPV+ oropharyngeal squamous cell carcinoma (OPSCC) patients and evaluated the impact of chemoradiotherapy (CRT).Methods: Saliva, oropharyngeal swabs over the tumour site and stool were collected at baseline and post-CRT. 16S RNA and shotgun metagenomic sequencing were used to generate taxonomic profiles, including relative abundance (RA), bacterial density, α-diversity and β-diversity.Results: A total of 132 samples from 22 patients were analysed. Baseline saliva and swabs had similar taxonomic composition (R2 = 0.006; p = 0.827). Oropharyngeal swabs and stool taxonomic composition varied significantly by stage, with increased oral RA of Fusobacterium nucleatum observed in stage III disease (p < 0.05). CRT significantly reduced the species richness and increased the RA of gut-associated taxa in oropharyngeal swabs (p < 0.05), while it had no effect in stool samples. These findings remained significant when adjusted by stage, smoking status and antibiotic use.Conclusions: Baseline oral and gut microbiomes differ by stage in this HPV+ cohort. CRT caused a shift towards a gut-like microbiome composition in oropharyngeal swabs. Stage-specific features and the transitions in oral microbiome might have prognostic and therapeutic implications. [ABSTRACT FROM AUTHOR]